رجوع
46
14
نطاق اليوم
KWD 8.37
KWD 8.64
نطاق 52 أسبوعًا
KWD 8.07
KWD 15.48
حجم التداول
325,697
متوسط 50 يوم / 200 يوم
KWD 9.02
/
KWD 11.35
الإغلاق السابق
KWD 8.64
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 9.1 | 0.3 |
| P/B | 0.7 | 2.9 |
| ROE % | 9.6 | 3.7 |
| Net Margin % | 2.2 | 3.8 |
| Rev Growth 5Y % | 6.8 | 10.0 |
| D/E | 1.3 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 14.140
+64.6%
Low: KWD 12.000
High: KWD 19.000
مكرر الربحية المستقبلي
7.6
ربحية السهم المستقبلية
KWD 1.143
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
6.6 B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2028 |
KWD 1.339
KWD 1.067 – KWD 1.575
|
7.2 B | 6 |
| FY2027 |
KWD 1.255
KWD 1.021 – KWD 1.480
|
6.9 B | 6 |
| FY2026 |
KWD 1.143
KWD 1.034 – KWD 1.369
|
6.6 B | 7 |
النقاط الرئيسية
Revenue grew 6.75% annually over 5 years — modest growth
Earnings declined -35.43% over the past year
Generating 258.61M in free cash flow
P/E of 9.06 — trading at a low valuation
Cash machine — converts 190.42% of earnings into free cash flow
Capital efficient — spends only 3.35% of revenue on capex
النمو
Revenue Growth (5Y)
6.75%
Revenue (1Y)6.01%
Earnings (1Y)-35.43%
FCF Growth (3Y)75.16%
الجودة
Return on Equity
9.64%
ROIC6.18%
Net Margin2.15%
Op. Margin5.15%
الأمان
Debt / Equity
1.34
Current Ratio1.97
Interest Coverage5.90
التقييم
P/E Ratio
9.06
P/B Ratio0.73
EV/EBITDA8.55
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6.01% | Revenue Growth (3Y) | 8.13% |
| Earnings Growth (1Y) | -35.43% | Earnings Growth (3Y) | 64.33% |
| Revenue Growth (5Y) | 6.75% | Earnings Growth (5Y) | -3.13% |
| Profitability | |||
| Revenue (TTM) | 6.32B | Net Income (TTM) | 135.81M |
| ROE | 9.64% | ROA | 2.57% |
| Gross Margin | 97.54% | Operating Margin | 5.15% |
| Net Margin | 2.15% | Free Cash Flow (TTM) | 258.61M |
| ROIC | 6.18% | FCF Growth (3Y) | 75.16% |
| Safety | |||
| Debt / Equity | 1.34 | Current Ratio | 1.97 |
| Interest Coverage | 5.90 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 9.06 | P/B Ratio | 0.73 |
| P/S Ratio | 0.19 | PEG Ratio | -0.23 |
| EV/EBITDA | 8.55 | Dividend Yield | 0.00% |
| Market Cap | 1.23B | Enterprise Value | 2.78B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6.32B | 5.97B | 5.41B | 5.13B | 4.87B |
| Net Income | 135.81M | 210.34M | 50.29M | 188.91M | 154.26M |
| EPS (Diluted) | 0.96 | 1.58 | 0.35 | 1.32 | 1.08 |
| Gross Profit | 6.17B | 4.93B | 5.27B | 4.17B | 3.94B |
| Operating Income | 325.58M | 405.76M | 229.50M | 217.03M | 436.56M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2018 |
|---|---|---|---|---|---|
| Total Assets | 5.29B | 4.96B | 5.10B | 4.86B | 2.75B |
| Total Liabilities | 3.61B | 3.43B | 4.02B | 3.81B | 2.03B |
| Shareholders' Equity | 1.69B | 1.13B | 670.90M | 639.05M | 331.65M |
| Total Debt | 2.26B | 2.28B | 2.40B | 2.39B | 1.26B |
| Cash & Equivalents | 709.60M | 556.79M | 437.58M | 456.12M | 59.66M |
| Current Assets | 2.06B | 1.83B | 1.62B | 1.41B | 860.42M |
| Current Liabilities | 1.05B | 945.42M | 994.10M | 808.60M | 624.83M |
درجات الاستراتيجيات
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#501 of 1052
#519 of 618
النشاط الأخير
دخل
Cash Flow Compounder
Mar 24, 2026
دخل
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026